ADVENZYMES:NSE-Advanced Enzyme Technologies Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 315.15

Change

-0.35 (-0.11)%

Market Cap

INR 35.56B

Volume

0.61M

Avg Analyst Target

INR 282.50 (-10.36%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ADVENZYMES Stock Forecast & Price:
Based on the Advanced Enzyme Technologies Limited stock forecasts from 1 analysts, the average analyst target price for Advanced Enzyme Technologies Limited is INR 282.50 over the next 12 months. Advanced Enzyme Technologies Limited’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Advanced Enzyme Technologies Limited is Bearish, which is based on 3 positive signals and 11 negative signals. At the last closing, Advanced Enzyme Technologies Limited’s stock price was INR 315.15. Advanced Enzyme Technologies Limited’s stock price has changed by +10.97% over the past week, +10.31% over the past month and -5.84% over the last year.

About Advanced Enzyme Technologies Limited (ADVENZYMES:NSE)

Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition, fruit and vegetable processing, bak ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-07 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

+64.80 (+2.05%)

INR3,081.36B 83.41 49.58
PIDILITIND:NSE Pidilite Industries Limited

+15.20 (+0.55%)

INR1,386.49B 106.76 68.53
SRF:NSE SRF Limited

-12.40 (-0.52%)

INR714.09B 32.45 20.45
BERGEPAINT:NSE Berger Paints (I) Limited

+2.85 (+0.46%)

INR601.70B 63.60 38.70
SOLARINDS:NSE Solar Industries India Limited

-2.45 (-0.06%)

INR369.97B 60.00 36.40
LINDEINDIA:NSE Linde India Limited

+82.25 (+2.67%)

INR263.89B 65.59 40.82
ATUL:NSE Atul Limited

-235.05 (-2.70%)

INR252.25B 41.61 25.81
AARTIIND:NSE Aarti Industries Limited

-6.50 (-0.97%)

INR242.15B 19.30 13.96
KANSAINER:NSE Kansai Nerolac Paints Limited

+0.35 (+0.08%)

INR240.69B 56.82 31.09
VINATIORGA:NSE Vinati Organics Limited

+29.55 (+1.41%)

INR218.62B 55.16 37.82

ETFs Containing ADVENZYMES

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.36% 55% F 47% F
Dividend Return 0.31% 27% F 18% F
Total Return -3.05% 53% F 46% F
Trailing 12 Months  
Capital Gain -6.99% 47% F 35% F
Dividend Return 0.30% 27% F 16% F
Total Return -6.70% 45% F 35% F
Trailing 5 Years  
Capital Gain 11.24% 46% F 51% F
Dividend Return 1.16% 8% F 17% F
Total Return 12.41% 46% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 20.94% 51% F 56% F
Dividend Return 0.26% 18% F 23% F
Total Return 21.20% 51% F 55% F
Risk Return Profile  
Volatility (Standard Deviation) 66.90% 36% F 38% F
Risk Adjusted Return 31.69% 47% F 47% F
Market Capitalization 35.56B 69% D+ 68% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.11 36% F 30% F
Price/Book Ratio 2.95 48% F 40% F
Price / Cash Flow Ratio 29.08 39% F 26% F
EV/EBITDA 16.36 44% F 34% F
Management Effectiveness  
Return on Equity 11.39% 38% F 52% F
Return on Invested Capital 11.43% 44% F 65% D
Return on Assets 8.59% 57% F 77% C+
Debt to Equity Ratio 0.75% 78% C+ 80% B-
Technical Ratios  
Dividend Yield 0.33% 37% F 22% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.22 92% A- 89% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector